Lialda Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Lialda
P
- pamidronate
- Pamprin All Day Relief (naproxen)
- Panglobulin (immune globulin intravenous)
- Panglobulin NF (immune globulin intravenous)
- Panzyga (immune globulin intravenous)
- Partobulin SDF (rho (d) immune globulin)
- PediaCare Children's IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- PediaCare Infants' IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- pemetrexed
- Pemfexy (pemetrexed)
- Pemrydi RTU (pemetrexed)
- Pentacarinat (pentamidine)
- Pentam (pentamidine)
- Pentam 300 (pentamidine)
- pentamidine
- Penthrane (methoxyflurane)
- phenylbutazone
- piroxicam
- Platinol (cisplatin)
- Platinol-AQ (cisplatin)
- plazomicin
- Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- Polygam S/D (immune globulin intravenous)
- polymyxin b
- Ponstel (mefenamic acid)
- PrandiMet (metformin / repaglinide)
- Prandin (repaglinide)
- Prevacid NapraPAC (lansoprazole / naproxen)
- Prevacid NapraPAC 375 (lansoprazole / naproxen)
- Prevacid NapraPAC 500 (lansoprazole / naproxen)
- Privigen (immune globulin intravenous)
- ProFeno (fenoprofen)
- Prograf (tacrolimus)
- Proprinal (ibuprofen)
- ProQuad (measles virus vaccine / mumps virus vaccine / rubella virus vaccine / varicella virus vaccine)
- Purinethol (mercaptopurine)
- Purixan (mercaptopurine)
More about Lialda (mesalamine)
- Lialda consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (105)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: 5-aminosalicylates
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.